This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
2mbd
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | + | ==Lasiocepsin== | |
| - | === | + | <StructureSection load='2mbd' size='340' side='right' caption='[[2mbd]], [[NMR_Ensembles_of_Models | 48 NMR models]]' scene=''> |
| - | + | == Structural highlights == | |
| + | <table><tr><td colspan='2'>[[2mbd]] is a 1 chain structure. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2MBD OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2MBD FirstGlance]. <br> | ||
| + | </td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2mbd FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2mbd OCA], [http://www.rcsb.org/pdb/explore.do?structureId=2mbd RCSB], [http://www.ebi.ac.uk/pdbsum/2mbd PDBsum]</span></td></tr> | ||
| + | </table> | ||
| + | <div style="background-color:#fffaf0;"> | ||
| + | == Publication Abstract from PubMed == | ||
| + | Lasiocepsin is a unique 27-residue antimicrobial peptide, isolated from Lasioglossum laticeps (wild bee) venom, with substantial antibacterial and antifungal activity. It adopts a welldefined structure consisting of two alpha-helices linked by a structured loop. Its basic residues form two distinct positively charged regions on the surface whereas aliphatic side chains contribute to solvent-accessible hydrophobic areas, thus emphasising the amphipathic character of the molecule. Lasiocepsin structurally belongs to the ShK family and shows a strong preference for anionic phospholipids; this is further augmented by increasing concentrations of cardiolipin, such as those found at the poles of bacterial cells. The membrane-permeabilising activity of the peptide is not limited to outer membranes of Gram-negative bacteria. The peptide interacts with phospholipids initially through its N terminus, and its degree of penetration is strongly dependent on the presence of cardiolipin. | ||
| - | + | Structural Basis for Antimicrobial Activity of Lasiocepsin.,Monincova L, Budesinsky M, Cujova S, Cerovsky V, Veverka V Chembiochem. 2013 Dec 12. doi: 10.1002/cbic.201300509. PMID:24339323<ref>PMID:24339323</ref> | |
| - | + | ||
| - | == | + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> |
| - | + | </div> | |
| - | [[Category: Budesinsky, M | + | == References == |
| - | [[Category: Cerovsky, V | + | <references/> |
| - | [[Category: Cujova, S | + | __TOC__ |
| - | [[Category: Monincova, L | + | </StructureSection> |
| - | [[Category: Veverka, V | + | [[Category: Budesinsky, M]] |
| + | [[Category: Cerovsky, V]] | ||
| + | [[Category: Cujova, S]] | ||
| + | [[Category: Monincova, L]] | ||
| + | [[Category: Veverka, V]] | ||
[[Category: Antimicrobial peptide]] | [[Category: Antimicrobial peptide]] | ||
[[Category: Antimicrobial protein]] | [[Category: Antimicrobial protein]] | ||
[[Category: Venom]] | [[Category: Venom]] | ||
[[Category: Wild bee]] | [[Category: Wild bee]] | ||
Revision as of 17:49, 21 December 2014
Lasiocepsin
| |||||||||||
